CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity
Molecular Cell · 2023-12 · 83 (23) · 4370-4385.e9
DOI: 10.1016/j.molcel.2023.10.043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2023-12. Verfasst von Guiheng Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, and Department of Respiratory Disease of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310…. Hauptthemen laut MEDLINE: Interferon Type I, Virus Diseases. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Targeting epigenetic regulators to potentiate anti-PD-1 immunotherapy converges on the activation of type I interferon (IFN-I) response, mimicking cellular response to viral infection, but how its strength and duration are regulated to impact combination therapy efficacy remains largely unknown. Here, we show that mitochondrial CPT1A downregulation following viral infection restrains, while its induction by epigenetic perturbations sustains, a double-stranded RNA-activated IFN-I response. Mechanistically, CPT1A recruits the endoplasmic reticulum-localized ZDHHC4 to catalyze MAVS Cys79-palmitoylation, which promotes MAVS stabilization and activation by inhibiting K48- but facilitating K63-linked ubiquitination. Further elevation of CPT1A incrementally increases MAVS palmitoylation and amplifies the IFN-I response, which enhances control of viral infection and epigenetic perturbation-induced antitumor immunity. Moreover, CPT1A chemical inducers augment the therapeutic effect of combined epigenetic treatment with PD-1 blockade in refractory tumors. Our study identifies CPT1A as a stabilizer of MAVS activation, and its link to epigenetic perturbation can be exploited for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology, and Department of Respiratory Disease of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China; Liangzhu Laboratory, Zhejiang University Medical…
- Department of Human Anatomy, Histology and Embryology, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China.
- Ludwig Institute for Cancer Research, University of Oxford, Oxford OX3 7DQ, UK.
- Department of Respiratory Disease of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.
- International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu 322000, Zhejiang, China.
- Ludwig Institute for Cancer Research, University of Oxford, Oxford OX3 7DQ, UK. Electronic address: yang.shi@ludwig.ox.ac.uk.
Zitieren
APA
Zhang, G., Jiang, P., Tang, W., Wang, Y., Qiu, F., An, J., Zheng, Y., Wu, D., Zhou, J., Neculai, D., Shi, Y., & Sheng, W. (2023). CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Molecular Cell, 83(23), 4370-4385.e9. https://doi.org/10.1016/j.molcel.2023.10.043
Vancouver
Zhang G, Jiang P, Tang W, Wang Y, Qiu F, An J, et al. CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Molecular Cell. 2023;83(23):4370-4385.e9. doi:10.1016/j.molcel.2023.10.043
BibTeX
@article{Zhang2023,
author = {Zhang, Guiheng and Jiang, Peishan and Tang, Wen and Wang, Yunyi and Qiu, Fengqi and An, Jie and Zheng, Yuping and Wu, Dandan and Zhou, Jianya and Neculai, Dante and Shi, Yang and Sheng, Wanqiang},
title = {CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity},
journal = {Molecular Cell},
year = {2023},
volume = {83},
number = {23},
pages = {4370--4385.e9},
doi = {10.1016/j.molcel.2023.10.043}
}
EUVIMED